CSIMarket Company Name, Ticker, Customers, else..
 
Trevi Therapeutics Inc   (NASDAQ: TRVI)
 

Trevi Therapeutics Inc's Suppliers Performance

TRVI's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
TRVI Costs vs Sales of Suppliers Growth

• More on TRVI Suppliers






Trevi Therapeutics Inc's Comment on Supply Chain


The company sources nalbuphine hydrochloride drug substance from Par Health, which became an independent company following the merger of Mallinckrodt plc and Endo, Inc. There are no agreements in place that guarantee supply quantities or pricing with Par Health. Any delays or issues in obtaining nalbuphine hydrochloride could affect the manufacturing of Haduvio, potentially impacting clinical trials and commercialization. The company is evaluating alternative sources but has not yet qualified any. Haduvio is produced from readily available starting materials using scalable processes that do not require special equipment. Current suppliers and manufacturers have the capacity for commercial-scale production; however, no formal agreements exist for commercial production. The company may pursue additional or alternative suppliers in the future, which could result in increased costs or delays.

Trevi Therapeutics Inc's Comment on Supply Chain


The company sources nalbuphine hydrochloride drug substance from Par Health, which became an independent company following the merger of Mallinckrodt plc and Endo, Inc. There are no agreements in place that guarantee supply quantities or pricing with Par Health. Any delays or issues in obtaining nalbuphine hydrochloride could affect the manufacturing of Haduvio, potentially impacting clinical trials and commercialization. The company is evaluating alternative sources but has not yet qualified any. Haduvio is produced from readily available starting materials using scalable processes that do not require special equipment. Current suppliers and manufacturers have the capacity for commercial-scale production; however, no formal agreements exist for commercial production. The company may pursue additional or alternative suppliers in the future, which could result in increased costs or delays.







TRVI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Trevi Therapeutics Inc 2,274.65 0.00 -51.11 34
SUBTOTAL 0.00 0.00 0.00 -


Sources: Trevi Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Trevi Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.